any practitioners are now reaching for Xiidra (lifitegrast, Shire, Lexington, Massachusetts) 5% for dry eye cases, but sometimes a patient may not initially be considered a success. Here’s what leading practitioners are doing to help more patients find respite with Xiidra.
Though FDA approved, the Light Adjustable Lens (LAL, RxSight, Aliso Viejo, California) is not yet currently available in the U.S. Robert Maloney, MD, Los Angeles, John Doane, MD, Leawood, Kansas, David F. Chang, MD, Los Altos, California, and Kevin Waltz, MD, Indianapolis, discussed their experience with the lens in clinical trial, how it works, and for what corrections it has approval.
The right questions can be key to the early and correct diagnosis of various types of conjunctivitis.
About 1 in 5 Americans use antidepressants or anti-anxiety medications. With that large percentage, ophthalmologists probably encounter patients daily who use or have used these medications.
Today the goal of cataract surgery is to provide patients with the best possible quality of vision. While it is common to see patients post-cataract surgery with a visual acuity (VA) of 20/20, many patients remain dissatisfied with their quality of vision. This is due to several factors, including problems with the ocular surface, pseudophakic dysphotopsia, and optical aberrations in general.
Dry eye is the single most common reason that patients come into a practitioner’s office, with a prevalence of around 40% of those seeking ophthalmic care, according to Hank Perry, MD, Ophthalmic Consultants of Long Island, New York. What may not be clear in an office visit is that the patient’s sleep position may be a prime factor in his or her condition.